EP2954932 - Bibliographic data
UTILISATION THÉRAPEUTIQUE DE DIAMINOPHÉNOTHIAZINES
| Last update | 23/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
WisTa Laboratories Ltd. 25 Bukit Batok Crescent
The Elitist 06-13
Singapore 658066
Singapour
|
|---|---|
| (72) Inventors |
Claude Wischik WisTa Laboratories Ltd.
Institute of Medical Sciences
Forresterhill
Aberdeen, Aberdeenshire AB25 2ZD
Royaume-Uni
Damon Wischik University College London (UCL), Department of
Computer Science
Gower Street
London, Greater London WC1E 6BT
Royaume-Uni
John Storey WisTa Laboratories Ltd., Department of Chemistry
Meston Walk
Old Aberdeen, Aberdeenshire AB24 3UE
Royaume-Uni
Charles Harrington WisTa Laboratories Ltd., Institute of Medical
Sciences
Forresterhill
Aberdeen, Aberdeenshire AB25 2ZD
Royaume-Uni
|
| (74) Agent |
Mail recipient Mewburn Ellis LLP Aurora Building
Counterslip
Bristol BS1 6BX
Royaume-Uni
|
| (21) Request number | EP15161198.5 |
|---|---|
| (22) Request date | 01/10/2008 |
| (11) Publication number | EP2954932 |
|---|---|
| Publication date | 19/09/2018 |
| (54) Title of the invention | UTILISATION THÉRAPEUTIQUE DE DIAMINOPHÉNOTHIAZINES |
|---|---|
| (51) International classification | A61K 31/5415, A61P 25/28 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 960544 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 11 -
Amount: 200 € -
Due date 20/11/2018
Surtax: 11 - Amount: 40 € - Due date 21/05/2019 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 19/09/2018 Entrée en période de grâce du brevet d'invention - Legal date 21/11/2018 Modification du mandataire OEB du brevet européen - Legal date 21/12/2018 Déchéance du brevet d'invention après période de grâce - Legal date 20/11/2018 |